El tratamiento del dolor y la epidemia de opioides: hacia un equilibrio entre los beneficios sociales e individuales, y los riesgos del uso de opiáceos recetados

Publicaciones

El tratamiento del dolor y la epidemia de opioides: hacia un equilibrio entre los beneficios sociales e individuales, y los riesgos del uso de opiáceos recetados

31 julio 2017

Las Academias Nacionales de Ciencia, Ingeniería y Medicina de los Estados Unidos afirman que se necesita un esfuerzo sostenido y coordinado para detener la creciente prevalencia de los daños relacionados con los opioides.

Más información, en inglés, está disponible abajo.

Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas.

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA’s development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

Click here to read the full article. (Access Restricted)

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.